Not Disclosed
has agreed to be acquired by
Pending
Healthcare IT
Moritz-Benedikt Rottwinkel
Managing Director, Head of DACH Banking
About Moritz
Moritz-Benedikt Rottwinkel, partner, is a managing director and head of DACH banking for William Blair based in the firm’s Frankfurt office. He joined the investment banking team in 2012. Prior to William Blair, he worked for SEB Enskilda Corporate Finance and Lincoln International.
Languages Spoken
German
English
Notable Transactions
Not Disclosed
a portfolio company of Paragon Partners
has agreed to be acquired by
Pending
Medical Technology
William Blair acted as the exclusive M&A advisor to Primed, a portfolio company of Paragon, on its pending sale to Inflexion. The transaction signed July 2026.
Read more
Not Disclosed
a portfolio company of Genui
has partnered with
January 2026
Healthcare Services
$80,000,000
has acquired
a subsidiary of BICO Group AB
July 2025
Medical Technology
William Blair acted as financial advisor to Sartorius AG in connection with its acquisition of MatTek, a subsidiary of BICO Group AB.
Read more
Not Disclosed
has partnered with
April 2025
Medical Technology
William Blair acted as the exclusive M&A advisor to Armira on its partnership with Osypka AG.
Read more
Not Disclosed
a subsidiary of Sartorius AG
has merged with
July 2024
Healthcare IT
Not Disclosed
has acquired a majority stake in
July 2024
Medical Technology
William Blair acted as the exclusive financial advisor to Novo Holdings in connection with its pending majority stake acquisition of Single Use Support.
Read more
Not Disclosed
has partnered with
April 2024
Healthcare Services
William Blair acted as the exclusive financial advisor to TT medic GmbH and its shareholders in connection with entering a partnership with Trill Impact.
Read more
Not Disclosed
has been acquired by
October 2022
Medical Technology
William Blair acted as the exclusive financial advisor to CEVEC Pharmaceuticals in connection with its sale to Danaher Corporation (NYSE: DHR) and its portfolio company Cytiva.
Read more
Not Disclosed
a portfolio company of International Chemical Investors Group
has been acquired by
August 2022
Healthcare Services
William Blair acted as the exclusive financial advisor to International Chemical Investors Group in connection with its pending sale of its portfolio company, CordenPharma, to Astorg.
Read more
Not Disclosed
has been acquired by
February 2022
Healthcare Services
€123,000,000
has been acquired by
October 2021
Medical Technology
William Blair acted as financial advisor to Hemovent, a company backed by a consortium of institutional investors led by MIG Capital in connection with its sale to MicroPort (SEHK Ticker: 0853) for €123m in total consideration (including future milestone payments).
Read moreRigorous pursuit of your success. Every transaction. Every time.
Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.
More about investment banking at William Blair
Healthcare Services
William Blair’s Healthcare Services team is a trusted partner to providers, suppliers, and solutions providers across the healthcare continuum. Our knowledge of emerging healthcare trends and the nuances of reimbursement models have allowed us to help clients access capital and form valuable strategic partnerships.
More about our healthcare services expertise
About William Blair
William Blair is a premier global partnership with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 30 offices worldwide.*
-
1935Year William Blair was founded
-
2,100+Employees worldwide
-
156 billion+Client assets
-
90+ YearsIndependent and employee-owned
-
30+Offices worldwide*
-
700+Companies under coverage
As of June 30, 2026
*Includes strategic alliances with Allier Capital, BDA Partners, and Poalim Equity Ltd.